Replies to post #155708 on Bioelectronics Corp (BIEL)

[JNdouble1]

You shouldn’t disregard just because you don’t like the conclusion.

After reviewing the data, Lancashire does not recommend prescribing the device. This is important for investors to understand. We shouldn’t just ignore it.

http://www.lancsmmg.nhs.uk/download/newdrug%20reviews/Actipatch-for-web-site.pdf